Trk 02: Proj-Port Mgt-Strat Planning [
clear filter]
10:45am EDT
#126: Hope Is Not a Strategy: Quantifying Knowledge for Better Decision Making in Clinical Development
Chair
Associate Director, Biostatistics, PAREXEL
Colleen is an experienced pharmaceutical R&D statistician who has oversight of drug development and execution, insuring that work processes and client expectations are satisfied. She is focused on applying published statistical methods for comparing like devices to understand the...
Read More →
Speakers DB
Director, Biostatistics, Trevena Inc
David received his PhD in Statistics from Virginia Tech in 2000 and has since been working in the pharmaceutical industry for a number of different companies. Currently he is serving as the Director of Biostatistics at Trevena Inc a biotech company based out of King of Prussia, P...
Read More →
Associate Director, Biostatistics, PAREXEL
Sharon Murray is Associate Director, Statistics at PAREXEL Ltd. She provides statistical support for the design, analysis and operational aspects of Oncology clinical trials as well as for drug development strategy. Sharon holds an MS and PhD in Biostatistics from the University of...
Read More →
Monday June 27, 2016 10:45am - 12:00pm EDT
102AB
Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA
Trk 02: Proj-Port Mgt-Strat Planning,
Workshop
- Credit Type ACPE, CME, IACET, RN
- Audience Basic
- Featured Topics Clinical Trial Designs
- Interest Area Statistics, Clinical Research, R&D - Strategic Issues
- format json
- Interest Area Statistics,Clinical Research,R&D / Strategic Issues
- Featured Topics Clinical Trial Designs
- Credit Type ACPE, CME, IACET, RN
- Tags Workshop
10:30am EDT
4:00pm EDT
#358: Don’t Shoot the Messenger: Techniques for Delivering the Hard Messages
Chair DN
Director, Global Project Management, Merck & Co., Inc.
Global Project and Alliance Management at Merck
Speakers
Head, Bioethics-Based Science and Technology Policy, Johnson & Johnson, United States
Karla Childers is Head, Bioethics-based Science & Technology Policy in the Johnson & Johnson Office of the Chief Medical Officer. Her primary responsibility is leading and coordinating various bioethics-based, science policy projects since 2013. Her longest running responsibility...
Read More →
Wednesday June 29, 2016 4:00pm - 5:15pm EDT
102AB
Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA